Estrogen Receptor Negative clinical trials

Explore recruiting estrogen receptor negative clinical trials.

Recruiting estrogen receptor negative studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Estrogen Receptor Negative trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II clinical trial targeting estrogen receptor negative or PAM50 non-luminal disease with Atezolizumab in combination with Trastuzumab and Vinorelbine in HER2-positive advanced/metastatic breast cancer – ATREZZO Study

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Estrogen Receptor Negative trials by city

Estrogen Receptor Negative in Toronto Estrogen Receptor Negative in Vancouver Estrogen Receptor Negative in Montreal Estrogen Receptor Negative in Calgary Estrogen Receptor Negative in Edmonton Estrogen Receptor Negative in Ottawa Estrogen Receptor Negative in Winnipeg Estrogen Receptor Negative in Quebec City Estrogen Receptor Negative in Hamilton Estrogen Receptor Negative in Kitchener Estrogen Receptor Negative in London Estrogen Receptor Negative in Halifax Estrogen Receptor Negative in New York Estrogen Receptor Negative in Los Angeles Estrogen Receptor Negative in Chicago Estrogen Receptor Negative in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease